Mark Sullivan

4.3k total citations
112 papers, 3.1k citations indexed

About

Mark Sullivan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Mark Sullivan has authored 112 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 25 papers in Molecular Biology. Recurrent topics in Mark Sullivan's work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers) and Nitric Oxide and Endothelin Effects (10 papers). Mark Sullivan is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers) and Nitric Oxide and Endothelin Effects (10 papers). Mark Sullivan collaborates with scholars based in United Kingdom, United States and Taiwan. Mark Sullivan's co-authors include Ronald Vergona, Baby Martin-McNulty, Yi-Xin Wang, Dennis W. Wilson, John C. Rutledge, Valdeci da Cunha, Doris M. Tham, William P. Dole, Meredith Halks‐Miller and Jon Vincelette and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Mark Sullivan

112 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sullivan United Kingdom 33 923 784 778 723 407 112 3.1k
Nobuyuki Tanaka Japan 35 677 0.7× 367 0.5× 717 0.9× 1.1k 1.5× 250 0.6× 264 4.4k
John Orazem United States 24 708 0.8× 338 0.4× 560 0.7× 700 1.0× 404 1.0× 45 3.2k
Philippe Le Corvoisier France 28 733 0.8× 464 0.6× 893 1.1× 230 0.3× 152 0.4× 96 2.9k
Akihiko Kato Japan 41 644 0.7× 602 0.8× 2.0k 2.6× 496 0.7× 346 0.9× 223 5.1k
Yukio Kimura Japan 28 334 0.4× 647 0.8× 601 0.8× 476 0.7× 195 0.5× 191 2.9k
Marion A.H. Feijge Netherlands 35 460 0.5× 868 1.1× 723 0.9× 428 0.6× 157 0.4× 69 3.2k
Yang Xia United States 45 610 0.7× 582 0.7× 1.6k 2.1× 439 0.6× 389 1.0× 145 5.8k
Anindita Das United States 44 439 0.5× 1.7k 2.1× 2.6k 3.3× 550 0.8× 294 0.7× 103 5.2k
Hiroshi Yamaguchi Japan 33 456 0.5× 1.1k 1.5× 726 0.9× 1.3k 1.8× 334 0.8× 199 4.0k
Almut Grenz Germany 29 405 0.4× 375 0.5× 918 1.2× 583 0.8× 281 0.7× 50 3.6k

Countries citing papers authored by Mark Sullivan

Since Specialization
Citations

This map shows the geographic impact of Mark Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sullivan more than expected).

Fields of papers citing papers by Mark Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sullivan. The network helps show where Mark Sullivan may publish in the future.

Co-authorship network of co-authors of Mark Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sullivan. A scholar is included among the top collaborators of Mark Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sullivan. Mark Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conroy, Samantha, James W.F. Catto, Axel Bex, et al.. (2023). Diagnosis, treatment, and survival from kidney cancer: real‐world National Health Service England data between 2013 and 2019. British Journal of Urology. 132(5). 541–553. 2 indexed citations
2.
Biers, Suzanne, Noel A. Armenakas, Alastair Lamb, et al.. (2020). Urological Surgery. Oxford University Press eBooks. 1 indexed citations
3.
Vasudev, Naveen, Roisean E. Ferguson, Selina Bhattarai, et al.. (2019). UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time. Urology. 136. 162–168. 12 indexed citations
4.
Tran, Maxine, Katja K.H. Aben, Erik van Werkhoven, et al.. (2019). Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. British Journal of Urology. 125(1). 73–81. 20 indexed citations
5.
Tyrrell, Helen E.J., David N. Church, Johnson Joseph, et al.. (2017). Changing Practice Evaluation—Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols—Experience From a Supraregional Center. Clinical Genitourinary Cancer. 16(3). 240–244. 7 indexed citations
6.
Purshouse, Karin, Robert Watson, David N. Church, et al.. (2016). Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors. Clinical Genitourinary Cancer. 15(1). 152–156. 22 indexed citations
7.
Pang, Jingbo, Van Thi Nguyen, Davina Rhodes, et al.. (2016). Relationship of galectin-3 with obesity, IL-6, and CRP in women. Journal of Endocrinological Investigation. 39(12). 1435–1443. 30 indexed citations
8.
Hughes‐Hallett, Archie, et al.. (2013). Robot-Assisted Partial Nephrectomy: A Comparison of the Transperitoneal and Retroperitoneal Approaches. Journal of Endourology. 27(7). 869–874. 57 indexed citations
9.
Qian, Hu Sheng, Perry Liu, Katalin Kauser, et al.. (2007). Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice. Gene Therapy. 15(3). 224–232. 39 indexed citations
10.
Zhang, Le-Ning, Sharlene Velichko, Jon Vincelette, et al.. (2007). Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis. 197(1). 204–211. 28 indexed citations
11.
Tham, Doris M., et al.. (2005). PPAR-α activation attenuates angiotensin II-induced vascular inflammation, arterial LDL accumulation and endothelial layer permeability in mice. Journal of Applied Research. 5(1). 1–16. 1 indexed citations
12.
Li, Weiwei, et al.. (2005). Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. Toxicology in Vitro. 20(5). 669–676. 38 indexed citations
13.
Martin-McNulty, Baby, Jon Vincelette, Ronald Vergona, Mark Sullivan, & Yixin Wang. (2005). Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. Ultrasound in Medicine & Biology. 31(6). 745–749. 58 indexed citations
14.
Post, Joseph, et al.. (2002). Human in vitro pharmacodynamic profile of the selective Factor Xa inhibitor ZK-807834 (CI-1031). Thrombosis Research. 105(4). 347–352. 6 indexed citations
15.
Wang, Yi-Xin, Baby Martin-McNulty, Ling‐Yuh Huw, et al.. (2002). Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. Atherosclerosis. 162(1). 23–31. 70 indexed citations
16.
Wang, Yixin, Baby Martin-McNulty, Ana D. Freay, et al.. (2001). Angiotensin II Increases Urokinase-Type Plasminogen Activator Expression and Induces Aneurysm in the Abdominal Aorta of Apolipoprotein E-Deficient Mice. American Journal Of Pathology. 159(4). 1455–1464. 107 indexed citations
17.
Fitch, Richard M., Valdeci da Cunha, Katalin Kauser, et al.. (2001). Increased Nitric Oxide Accounts for Decreased Basal Vascular Tone and Responsiveness in the Resistance Vessels of High-Cholesterol-Fed Rabbits. Pharmacology. 63(4). 220–227. 6 indexed citations
18.
Sullivan, Mark, R.J. Morgan, Dimitri P. Mikhailidis, et al.. (2000). Inhibition of diabetic bladder smooth muscle cell proliferation by endothelin receptor antagonists. Urological Research. 28(4). 254–259. 1 indexed citations
19.
20.
Sullivan, Mark, et al.. (1990). Electrophysiological specificity of antiarrhythmic drugs: Is it necessary?. Drug Development Research. 19(2). 187–198. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuyuki Tanaka Breakdown of academic impact, for papers by John Orazem Breakdown of academic impact, for papers by Philippe Le Corvoisier Breakdown of academic impact, for papers by Akihiko Kato Breakdown of academic impact, for papers by Yukio Kimura Breakdown of academic impact, for papers by Marion A.H. Feijge Breakdown of academic impact, for papers by Yang Xia Breakdown of academic impact, for papers by Anindita Das Breakdown of academic impact, for papers by Hiroshi Yamaguchi Breakdown of academic impact, for papers by Almut Grenz
Rankless by CCL
2026